Dietary Sodium's Effect on Urinary Sodium and Dopamine Excretion in Patients With Postural Tachycardia Syndrome
Sponsor: National Heart, Lung, and Blood Institute (NHLBI)
Listed as NCT01563107, this NA trial focuses on Postural Orthostatic Tachycardia Syndrome and remains completed. Sponsored by National Heart, Lung, and Blood Institute (NHLBI), it has been updated 10 times since 2012, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
10 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Feb 2022 — Jul 2024 [monthly]
Completed NA
-
Jun 2021 — Feb 2022 [monthly]
Completed NA
Status: Active Not Recruiting → Completed
-
Jan 2021 — Jun 2021 [monthly]
Active Not Recruiting NA
▶ Show 5 earlier versions
-
May 2020 — Jan 2021 [monthly]
Active Not Recruiting NA
-
May 2019 — May 2020 [monthly]
Active Not Recruiting NA
-
Jun 2018 — May 2019 [monthly]
Active Not Recruiting NA
-
May 2017 — Jun 2018 [monthly]
Active Not Recruiting NA
-
Jan 2017 — May 2017 [monthly]
Active Not Recruiting NA
First recorded
Mar 2012
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- National Heart, Lung, and Blood Institute (NHLBI)
- Vanderbilt University Medical Center
For direct contact, visit the study record on ClinicalTrials.gov .